RE:"Nitrogen Scavenging Properties" This study result was 100% telegraphed and expected that they would tank 4050 despite the early success in fibrosis on Alstrom and IPF. So, someone is lying. Was it previous management of Pierre Laurin and Dr John Moran or was it Thomvest / current management who recapitalized PLi? With many trials completed previously with top scientists, they found strong fibrosis candidates. Now, with a technical team led by a consultant, it takes 15 months to deduce that there is no value to 4050 as a fibrosis drug?
if they knew there was no value to 4050 in fibrosis, why would they give Pierre Laurin's company $400k and a royalty stream for the IP last month? Why would Thomvest get rid of their top scientists like Lynn Gagnon who led 4050 development when small molecule division was where their focus would be. As usual, something is rotten in the state of PLI.
37minus4 wrote: Well that is some thin gruel, boy.
Maybe they can add some of their "scavenged nitrogen" to the poutine in the poutine shack.
Tasty.
;-/
33